Suppr超能文献

通过使用添加牛血清白蛋白的 CLSI M27-A3 文档方法,提高对 Candida sp. fks 热点突变体的检测。

Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin.

机构信息

Public Health Research Institute, New Jersey Medical School-UMDNJ, Newark, NJ 07103-3535, USA.

出版信息

Antimicrob Agents Chemother. 2011 May;55(5):2245-55. doi: 10.1128/AAC.01350-10. Epub 2011 Mar 7.

Abstract

Echinocandins are highly bound to serum proteins, altering their antifungal properties. The addition of 50% human serum to the MIC assay improves the identification of echinocandin-resistant Candida spp. harboring fks hot spot mutations. However, this modification cannot readily be applied to the method of the CLSI M27-A3 document due to safety and standardization difficulties. The aim of this study was to evaluate commercial bovine serum albumin (BSA) as a safe and standardized alternative to human serum. A collection of 28 echinocandin-susceptible strains, 10 Candida parapsilosis sensu lato strains (with naturally reduced echinocandin susceptibility), and 40 FKS hot spot mutants was used in this work. When RPMI 1640 was used for susceptibility testing, wild-type strains and fks mutants showed MIC range overlaps (-2, -1, and -3 2-fold-dilution steps separated these populations for anidulafungin, caspofungin, and micafungin, respectively). On the other hand, the addition of BSA to RPMI 1640 differentially increased echinocandin MIC values for these groups of strains, allowing better separation between populations, with no MIC range overlaps for any of the echinocandin drugs tested. Moreover, the use of RPMI-BSA reduced the number of fks hot spot mutant isolates for which MIC values were less than or equal to the upper limit for the wild type (very major errors) from 9, 2, and 7 with RPMI alone to 3, 0, and 3 for anidulafungin, caspofungin, and micafungin, respectively. When RPMI-BSA was used to study the susceptibility of C. parapsilosis sensu lato species to echinocandins, the strains behaved as anidulafungin- and micafungin-resistant isolates (MIC, ≥8 μg/ml). These data support the need for a revision of the CLSI protocol for in vitro testing of echinocandin susceptibility in order to identify all or most of the fks hot spot mutants. Also, caspofungin could be used as a surrogate marker of reduced susceptibility to echinocandins.

摘要

棘白菌素类药物与血清蛋白高度结合,改变其抗真菌特性。将 50%人血清加入 MIC 测定中,可以提高对携带 fks 热点突变的棘白菌素类耐药念珠菌的鉴定。然而,由于安全性和标准化方面的困难,这种改良不能轻易应用于 CLSI M27-A3 文件中的方法。本研究旨在评估商业牛血清白蛋白(BSA)作为一种安全且标准化的人血清替代物。本研究使用了 28 株棘白菌素类敏感株、10 株近平滑念珠菌(具有天然降低的棘白菌素类敏感性)和 40 株 FKS 热点突变株。当使用 RPMI 1640 进行药敏试验时,野生型菌株和 fks 突变株的 MIC 范围存在重叠(阿尼达霉素、卡泊芬净和米卡芬净分别用 2 倍稀释步骤区分了这两种群体)。另一方面,BSA 对 RPMI 1640 的添加,使这些菌株群体的棘白菌素类 MIC 值有差异增加,更好地分离了不同群体,在测试的任何一种棘白菌素类药物中,MIC 范围均无重叠。此外,使用 RPMI-BSA 可减少 MIC 值等于或低于野生型上限(非常大的错误)的棘白菌素类 FKS 热点突变株分离株的数量,从单独使用 RPMI 时的 9、2 和 7 株,分别减少到阿尼达霉素、卡泊芬净和米卡芬净的 3、0 和 3 株。当使用 RPMI-BSA 研究近平滑念珠菌对棘白菌素类药物的敏感性时,这些菌株表现为阿尼达霉素和米卡芬净耐药分离株(MIC≥8μg/ml)。这些数据支持需要修订 CLSI 体外棘白菌素类药敏试验协议,以鉴定所有或大多数 FKS 热点突变株。此外,卡泊芬净可作为棘白菌素类药物敏感性降低的替代标志物。

相似文献

1
10
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
J Clin Microbiol. 2011 Jul;49(7):2516-21. doi: 10.1128/JCM.00201-11. Epub 2011 May 4.

引用本文的文献

1
A new PK/PD target for assessing efficacy of micafungin against Candida parapsilosis.
J Antimicrob Chemother. 2024 Jan 3;79(1):157-165. doi: 10.1093/jac/dkad360.
3
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy.
Front Cell Infect Microbiol. 2020 Jul 7;10:326. doi: 10.3389/fcimb.2020.00326. eCollection 2020.
4
Loss of Kex2 Affects the Cell Wall and Interaction with Innate Immune Cells.
J Fungi (Basel). 2020 Apr 29;6(2):57. doi: 10.3390/jof6020057.
6
Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
Mycopathologia. 2017 Dec;182(11-12):979-987. doi: 10.1007/s11046-017-0178-9. Epub 2017 Jul 11.
7
Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species.
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6100-7. doi: 10.1128/AAC.00620-16. Print 2016 Oct.
8
Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.
Antimicrob Agents Chemother. 2015 Dec 7;60(3):1226-33. doi: 10.1128/AAC.02026-15.
9
Dose escalation studies with caspofungin against Candida glabrata.
J Med Microbiol. 2015 Sep;64(9):998-1007. doi: 10.1099/jmm.0.000116. Epub 2015 Jun 30.
10
Diverse nitrogen sources in seminal fluid act in synergy to induce filamentous growth of Candida albicans.
Appl Environ Microbiol. 2015 Apr;81(8):2770-80. doi: 10.1128/AEM.03595-14. Epub 2015 Feb 6.

本文引用的文献

1
Breakthrough invasive candidiasis in patients on micafungin.
J Clin Microbiol. 2010 Jul;48(7):2373-80. doi: 10.1128/JCM.02390-09. Epub 2010 Apr 26.
2
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
Antimicrob Agents Chemother. 2010 Jun;54(6):2655-9. doi: 10.1128/AAC.01711-09. Epub 2010 Apr 5.
3
Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans.
Antimicrob Agents Chemother. 2010 May;54(5):1753-61. doi: 10.1128/AAC.01728-09. Epub 2010 Mar 1.
6
Antifungal activity of micafungin in serum.
Antimicrob Agents Chemother. 2009 Oct;53(10):4559-62. doi: 10.1128/AAC.01404-08. Epub 2009 Aug 17.
8
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Antimicrob Agents Chemother. 2009 May;53(5):2192-5. doi: 10.1128/AAC.01543-08. Epub 2009 Feb 17.
10
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Antimicrob Agents Chemother. 2008 Nov;52(11):4181-3. doi: 10.1128/AAC.00802-08. Epub 2008 Sep 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验